• N1-Methylpseudouridine: Mechanistic Advances in mRNA Transla

  2026-06-10

  Explore the scientific mechanisms behind N1-Methylpseudouridine, a leading modified nucleoside for mRNA translation enhancement. This article uncovers how its unique action surpasses common approaches and offers new insights for advanced protein expression strategies.

• JNJ-26481585 (Quisinostat): Advanced HDAC Inhibition for Tum

  2026-06-09

  Explore how JNJ-26481585 (Quisinostat), a potent HDAC inhibitor, uniquely disrupts TRIM21-mediated drug resistance and cell proliferation in cancer research. This article delves into its molecular mechanism and practical implications for advanced assay design.

• Hoechst 33258 in Live-Cell DNA Staining: Mechanobiology, Lim

  2026-06-09

  Discover how Hoechst 33258, a bis-benzimide DNA stain, is revolutionizing live-cell mechanobiology research. This article explores advanced protocols, mechanistic insights, and practical assay considerations that go beyond standard applications.

• Efficient Synthesis of Deuterium-Labeled Degarelix Acetate:

  2026-06-08

  This study introduces a streamlined 13-step synthesis of deuterium-labeled degarelix acetate, a key standard for pharmacokinetic research of GnRH antagonists in androgen-related disease. The protocol offers improved reliability and enables advanced metabolic and clinical studies requiring stable isotope internal standards.

• Hoechst 33258: Applied Bis-Benzimide DNA Stain Workflows

  2026-06-08

  Hoechst 33258 empowers researchers to visualize DNA in live and fixed cells with precision, especially in workflows probing tumor pH disruption and cell cycle status. Its spectral properties, cell-permeability, and compatibility with microscopy and flow cytometry make it a cornerstone for advanced oncology and metabolic studies.

• 3-Bromopyruvate Restores Cetuximab Sensitivity via Autophagy

  2026-06-07

  This study demonstrates that co-treatment with 3-bromopyruvate and cetuximab overcomes resistance in colorectal cancer cells by triggering autophagy-dependent ferroptosis and apoptosis. The findings reveal new mechanistic targets for bypassing therapeutic resistance and inform protocols for autophagy and ferroptosis modulation in cancer research.

• RIPA Lysis Buffer (Strong, without inhibitors): Technical Us

  2026-06-06

  RIPA Lysis Buffer (Strong, without inhibitors) delivers strong detergent-based lysis of animal cells and tissues, enabling efficient protein extraction for immunological and biochemical assays. It is ideal for workflows requiring customizable inhibitor addition and rapid sample processing. This buffer is not recommended when immediate protease or phosphatase inhibition is essential or where delays in sample handling are expected.

• CD44-Driven Metabolic Rewiring in IDH1-Mutant Leukemia

  2026-06-05

  The reference study uncovers that CD44-mediated metabolic rewiring is a critical dependency in IDH-mutant acute myeloid leukemia (AML), enabling sustained NADPH production and accumulation of the oncometabolite 2-hydroxyglutarate. This discovery highlights a novel therapeutic avenue, suggesting that targeting both CD44 and mutant IDH1 could overcome resistance and improve outcomes in AML.

• AG-120 (Ivosidenib): Reliable IDH1 Inhibition in AML Assays

  2026-06-05

  This article explores real-world laboratory challenges in AML research and demonstrates how AG-120 (Ivosidenib), mutant IDH1 inhibitor (SKU B7805), delivers robust solutions for cell viability, 2-hydroxyglutarate reduction, and myeloid differentiation workflows. Drawing on published data and validated protocols, it addresses experimental design, troubleshooting, and product reliability for scientists seeking reproducible, data-backed results.

• Jasplakinolide: Precision Actin Polymerization Inducer in Re

  2026-06-04

  Jasplakinolide stands out as a membrane-permeable actin polymerization inducer, enabling unparalleled control over cytoskeletal dynamics in both basic and translational research. With optimized workflows, robust troubleshooting strategies, and unique assay flexibility, APExBIO’s Jasplakinolide empowers researchers to dissect actin-dependent processes with unmatched precision.

• EZ Cap™ Firefly Luciferase mRNA: Optimizing mRNA Delivery As

  2026-06-04

  EZ Cap™ Firefly Luciferase mRNA, featuring a Cap 1 structure and optimized poly(A) tail, unlocks reliable, high-sensitivity bioluminescent assays for gene regulation and in vivo imaging. Its robust design streamlines mRNA delivery workflows, enhances translation efficiency, and enables reproducible results even in challenging experimental setups.

• ML133 HCl: Precision Potassium Channel Inhibitor for Kir2.1

  2026-06-03

  ML133 HCl is a highly selective potassium channel inhibitor, enabling researchers to dissect Kir2.1 function in cardiovascular and pulmonary artery smooth muscle cell studies with confidence. Its robust selectivity, solubility, and protocol flexibility make it an indispensable tool for modeling disease mechanisms and validating novel therapeutic targets.

• Biotin (Vitamin B7): Coenzyme Function & Research Applicatio

  2026-06-03

  Biotin (Vitamin B7) is an essential water-soluble B-vitamin and a crucial coenzyme for multiple carboxylases. APExBIO’s high-purity Biotin A8010 supports precise protein biotinylation and sensitive molecular detection in research workflows. This article details the molecular rationale, mechanistic action, and validated protocols for using biotin in metabolic and labeling studies.

• Targeted mRNA Delivery to Islet β Cells via Lipid Nanopartic

  2026-06-02

  Enriquez et al. developed an eGLP-conjugated lipid nanoparticle system that enables efficient, β cell-selective mRNA delivery in mouse and human models. This platform demonstrates functional mRNA expression in islet β cells and delays autoimmune diabetes progression, offering a new avenue for mRNA-based β cell modulation.

• Optimizing ARCA Capped mRNA Synthesis: Insights From HyperSc

  2026-06-02

  Discover how the HyperScribe All in One mRNA Synthesis Kit empowers next-generation mRNA vaccine synthesis with precise ARCA capping and polyadenylation. This in-depth guide analyzes the latest mechanistic research and offers unique protocol insights for translational and immunotherapy applications.

314 records 6/21 page Previous Next First page 上5页 678910 下5页 Last page